HIV vector expressing CRISPR* spCas9 nuclease under the control of the TRE (TET Response Element)-promoter, activated in the presence of Doxycycline by the tetracycline transactivator rtTA (Tet-On system). Puromycin-selectable marker and VSVG envelope. Flag epitope-tagged spCas9. T2A self-cleaving peptide. *Additional royalty fees apply to this technology.MTA required with Salk Institute for first time external customers. Please contact us at firstname.lastname@example.org for information on initiating the agreement.
*These listed prices are per aliquot for non-profit customers only, additional fees may apply.